Inspire Medical Systems, Inc.
INSP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $225 | $217 | $201 | $240 |
| % Growth | 3.4% | 7.8% | -16% | – |
| Cost of Goods Sold | $32 | $35 | $31 | $36 |
| Gross Profit | $193 | $182 | $171 | $204 |
| % Margin | 85.8% | 84% | 84.7% | 85% |
| R&D Expenses | $24 | $26 | $28 | $30 |
| G&A Expenses | $122 | $135 | $0 | $0 |
| SG&A Expenses | $159 | $160 | $144 | $142 |
| Sales & Mktg Exp. | $36 | $25 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $183 | $186 | $172 | $172 |
| Operating Income | $10 | -$3 | -$1 | $32 |
| % Margin | 4.3% | -1.5% | -0.7% | 13.3% |
| Other Income/Exp. Net | $4 | $1 | $6 | $5 |
| Pre-Tax Income | $14 | -$2 | $4 | $37 |
| Tax Expense | $4 | $1 | $1 | $1 |
| Net Income | $10 | -$4 | $3 | $35 |
| % Margin | 4.4% | -1.7% | 1.5% | 14.7% |
| EPS | 0.34 | -0.12 | 0.1 | 1.18 |
| % Growth | 383.3% | -220% | -91.5% | – |
| EPS Diluted | 0.34 | -0.12 | 0.1 | 1.15 |
| Weighted Avg Shares Out | 29 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 30 | 30 | 30 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $4 | $5 | $6 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $4 | $3 | $3 | $2 |
| EBITDA | $17 | $1 | $2 | $57 |
| % Margin | 7.7% | 0.5% | 0.8% | 23.7% |